Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 185

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

NF-κB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity

Open access
Xu, Anji, Deng, Feiyan, Chen, Yongyi, Kong, Yu, Pan, Lijun, Liao, Qianjin, Rao, Zhen, Xie, Luyuan, Yao, Chaoling, Li, Sha, Zeng, Xiaoling, Zhu, Xiaomei, Liu, Huayun, Gao, Nina, Xue, Lei, Chen, Fen, Xu, Guoxing, Wei, Di, Zhou, Xiao, Li, Zan, Sheng, Xiaowu · 2020 · Biomedicine & Pharmacotherapy

Abstract

Doxorubicin is a commonly used anthracycline chemotherapeutic agent; however, its application is limited owing to its cardiotoxicity. Current clinical treatments cannot efficiently or fully prevent doxorubicin-induced toxicity, primarily because its pathogenesis and mechanisms of action remain unknown. In this study, we established a rat model of chronic doxorubicin-induced cardiotoxicity, in which the severity of cardiac fibrosis and hydroxyproline levels increased in a time-dependent manner. Doxorubicin damaged the mitochondria and blood vessels and induced autophagy. Cells undergoing endothelial-to-mesenchymal transition (EndoMT)and those expressing endothelial cell and myofibroblast markers were simultaneously observed in vitro and in rats treated with doxorubicin. The NF-κB pathway was activated during EndoMT, andp65 and p-p65 were strongly expressed in the nucleus of endothelial cells in vitro. Taken together, these results suggest that vascular injury and cardiac fibrosis are characteristic symptoms of doxorubicin-induced cardiotoxicity. The NF-κB pathway-associated EndoMT may influence the pathogenesis of doxorubicin-induced cardiotoxicity, and the constituents of this pathway may be potential therapeutic targets to prevent the development of this condition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2020.110525

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 185

Metadata

Authors
Xu, A., Deng, F., Chen, Y., Kong, Y., Pan, L., Liao, Q., Rao, Z., Xie, L., Yao, C., Li, S., Zeng, X., Zhu, X., Liu, H., Gao, N., Xue, L., Chen, F., Xu, G., Wei, D., Zhou, X., Li, Z., & Sheng, X.
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2020-10
Volume
130
Pages
110525
ISSN
0753-3322 (ISSN-L)
OpenAlex
W3044177990
Cited by
185
References
3
FWCI
2.37
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NF-κB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity. https://app.cochat.ai/papers/10.1016/j.biopha.2020.110525
The paper
Xu, A., Deng, F., Chen, Y., Kong, Y., Pan, L., Liao, Q., Rao, Z., Xie, L., Yao, C., Li, S., Zeng, X., Zhu, X., Liu, H., Gao, N., Xue, L., Chen, F., Xu, G., Wei, D., Zhou, X., . . . Sheng, X. (2020). NF-κB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2020.110525

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.